Department of Urology, Pediatric Urology and Urologic Oncology; St. Antonius-Hospital Gronau GmbH
Gronau, 48599, Germany
NCT Number: NCT02108431
The purpose of the study is to determine, whether the urinary diversion via suprapubic cystostomy compared to transurethral catheterization after robot-assisted radical prostatectomy superior the postoperative patient comfort and reduce the postoperative bacteriuria.
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Not applicable
Gronau, 48599, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
suprapubic tube removal was allowed when the anastomosis was watertight, Day 5
Other names: UROMED, suprapubic tube, suprapubic device
transurethral catheter withdrawal was allowed when the anastomosis was watertight, Day 5
Other names: UROMED
Time frame: postoperatively on day 1, 2, 3, 4 and 5 in the morning, at noon and in the evening
To analyse the development of the postoperative pain related to urinary drainage patients completed NRS questionnaire three times a day: in the morning, at noon and in the evening until discharge of the catheter (regular 5 days after the surgery)
Time frame: 5th day after the surgery
Second void urine sample after catheter removal
St. Antonius Hospital Gronau
Other
Superior Postoperative Patient Comfort in Suprapubic Drainage Versus Transurethral Catheterization Following Robot-assisted Radical Prostatectomy: A Prospective Randomized Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06998121
Anxiety Disorders, Genital Diseases
Mersin, Turkey (Türkiye)
View Trial DetailsNCT00365105
Breast Cancer, Breast Diseases
Mobile, Alabama, United States
View Trial DetailsNCT05803096
Anxiety Disorders, Anxiety and Fear
Boston, Massachusetts, United States
View Trial DetailsNCT00303914
Breast Cancer, Breast Diseases
Chicago, Illinois, United States
View Trial Details